← Leaderboards
Kapil Bharti
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
- Sheldon Miller$0
- Peter F Kador$2,724,546
- M. Teresa Magone$0
- Chi-Chao Chan$0
- Karl G. Csaky$0
Others in their field
Top investigators on “Induced Pluripotent Stem Cell”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$77,143,245
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$72,554,837
- Joseph C Wu · Stanford University$63,140,589
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$50,800,152
- Li-Huei Tsai · Massachusetts Institute Of Technology$37,797,465
Research focus
Induced Pluripotent Stem CellPhotoreceptorsIn VitroTissuesMonolayerPharmaceutical PreparationsPathway InteractionsAffectCellsPre-ClinicalAge Related Macular DegenerationDisease ModelPhenotypeSamplingStructure Of Retinal Pigment EpitheliumBaseRetinaCell TherapyScaffoldCell LineLiquid SubstanceBlindnessApicalCell Death
Grant awards (51)
Developing an "aging" model using iPSC-derived RPE cells$2,304,044
ZIA · FY2025 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$1,548,029
ZIA · FY2025 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$1,422,027
ZIA · FY2025 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,206,023
ZIA · FY2025 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$3,030,638
ZIA · FY2024 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,237,383
ZIA · FY2024 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$1,911,946
ZIA · FY2024 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,444,129
ZIA · FY2024 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,883,025
ZIA · FY2023 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$2,482,712
ZIA · FY2023 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$2,182,477
ZIA · FY2023 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,963,074
ZIA · FY2023 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,586,989
ZIA · FY2022 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$2,012,880
ZIA · FY2022 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,988,376
ZIA · FY2022 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,918,362
ZIA · FY2022 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,655,942
ZIA · FY2021 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$1,715,813
ZIA · FY2021 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,700,299
ZIA · FY2021 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,529,649
ZIA · FY2021 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,921,648
ZIA · FY2020 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$1,916,197
ZIA · FY2020 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,564,812
ZIA · FY2020 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$973,986
ZIA · FY2020 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,836,940
ZIA · FY2019 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$1,450,454
ZIA · FY2019 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,291,642
ZIA · FY2019 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$729,819
ZIA · FY2019 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,659,709
ZIA · FY2018 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$1,644,542
ZIA · FY2018 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,156,355
ZIA · FY2018 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$761,834
ZIA · FY2018 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,219,219
ZIA · FY2017 · EY · contact PI
Developing 3D patient-specific iPS cell derived RPE/choroid models$1,598,816
ZIA · FY2017 · EY · contact PI
Developing an "aging" model using iPSC-derived RPE cells$1,155,138
ZIA · FY2017 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$183,772
ZIA · FY2017 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$2,850,386
ZIA · FY2016 · EY · contact PI
Developing patient-specific iPS cell derived RPE disease models$1,574,364
ZIA · FY2016 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$367,352
ZIA · FY2016 · EY · contact PI
Molecular and physiological authentication of iPS cell derived RPE$78,718
ZIA · FY2016 · EY · contact PI
Developing patient-specific iPS cell derived RPE disease models$1,191,744
ZIA · FY2015 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$719,277
ZIA · FY2015 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$712,226
ZIA · FY2015 · EY · contact PI
Molecular and physiological authentication of iPS cell derived RPE$91,673
ZIA · FY2015 · EY · contact PI
Developing autologous iPSC-RPE based IND for AMD patients$1,448,812
ZIA · FY2014 · EY · contact PI
Developing patient-specific iPS cell derived RPE disease models$1,066,796
ZIA · FY2014 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$623,106
ZIA · FY2014 · EY · contact PI
Molecular and physiological authentication of iPS cell derived RPE$121,227
ZIA · FY2014 · EY · contact PI
Developing functional and authenticated RPE tissue from iPS cells$494,749
ZIA · FY2013 · EY · contact PI
Developing patient-specific iPS cell derived RPE disease models$458,600
ZIA · FY2013 · EY · contact PI
Molecular and physiological authentication of iPS cell derived RPE$153,655
ZIA · FY2013 · EY · contact PI